Literature DB >> 2340275

Effect of the diaminocyclohexane carrier ligand on platinum adduct formation, repair, and lethality.

J D Page1, I Husain, A Sancar, S G Chaney.   

Abstract

Platinum compounds with the diaminocyclohexane (dach) carrier ligand are of particular interest because cell lines that have developed resistance to platinum compounds in general often retain sensitivity to dach-platinum compounds, suggesting that the dach carrier ligand affects the formation, repair, or lethality of platinum-DNA adducts. The effect of the dach ligand on platinum adduct formation was assessed by using the (HaeIII-HindIII)146 fragment of pBR322 treated to give equal amounts of dach- or ethylene-diamine-platinum adducts. The sites of adduct formation were mapped by digestion with Escherichia coli ABC excinuclease. There were no significant effects of the dach carrier ligand on the types or sites of platinum adduct formation. The effect of the dach ligand on platinum adduct repair was determined by using synthetic oligomers designed to have single, specific platinum adducts (G monoadduct; GG, AG, or GNG diadduct) with either the dach or ethylenediamine (en) carrier ligand. These adducts differed significantly in their ability to serve as substrates for ABC excinuclease with GNG greater than or equal to G greater than AG greater than GG. The dach carrier ligand had little effect on the recognition of AG and GG adducts by ABC excinuclease, but significantly improved the ability of ABC excinuclease to excise G monoadducts and GNG diadducts. These data suggest that if the carrier ligand has any effect on the repair of platinum adducts, it is more likely to exert that effect on the repair of platinum monoadducts or GNG diadducts rather than on the more abundant AG or GG diadducts. [14C]Thiourea incorporation was used to quantitate the rate of monoadduct to diadduct conversion.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2340275     DOI: 10.1021/bi00456a026

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  27 in total

1.  Killing of chronic lymphocytic leukemia by the combination of fludarabine and oxaliplatin is dependent on the activity of XPF endonuclease.

Authors:  Alma Zecevic; Deepa Sampath; Brett Ewald; Rong Chen; William Wierda; William Plunkett
Journal:  Clin Cancer Res       Date:  2011-06-01       Impact factor: 12.531

2.  Debio 0507 primarily forms diaminocyclohexane-Pt-d(GpG) and -d(ApG) DNA adducts in HCT116 cells.

Authors:  C L King; S Ramachandran; S G Chaney; L Collins; J A Swenberg; K E DeKrafft; W Lin; L Cicurel; M Barbier
Journal:  Cancer Chemother Pharmacol       Date:  2011-10-04       Impact factor: 3.333

3.  Conformation of DNA GG intrastrand cross-link of antitumor oxaliplatin and its enantiomeric analog.

Authors:  Jaroslav Malina; Olga Novakova; Marie Vojtiskova; Giovanni Natile; Viktor Brabec
Journal:  Biophys J       Date:  2007-08-17       Impact factor: 4.033

4.  Effect of geometric isomerism in dinuclear platinum antitumour complexes on the rate of formation and structure of intrastrand adducts with oligonucleotides.

Authors:  K J Mellish; Y Qu; N Scarsdale; N Farrell
Journal:  Nucleic Acids Res       Date:  1997-03-15       Impact factor: 16.971

5.  DNA interactions of antitumor cisplatin analogs containing enantiomeric amine ligands.

Authors:  J Malina; C Hofr; L Maresca; G Natile; V Brabec
Journal:  Biophys J       Date:  2000-04       Impact factor: 4.033

6.  A multi-center phase Ib study of oxaliplatin (NSC#266046) in combination with fluorouracil and leucovorin in pediatric patients with advanced solid tumors.

Authors:  Margaret E Macy; Tracey Duncan; James Whitlock; Stephen P Hunger; Jessica Boklan; Aru Narendren; Cynthia Herzog; Robert J Arceci; Rochelle Bagatell; Tanya Trippett; Uwe Christians; Katherine Rolla; S Percy Ivy; Lia Gore
Journal:  Pediatr Blood Cancer       Date:  2012-09-28       Impact factor: 3.167

7.  Solution structures of a DNA dodecamer duplex with and without a cisplatin 1,2-d(GG) intrastrand cross-link: comparison with the same DNA duplex containing an oxaliplatin 1,2-d(GG) intrastrand cross-link.

Authors:  Yibing Wu; Debadeep Bhattacharyya; Candice L King; Irene Baskerville-Abraham; Sung-Ho Huh; Gunnar Boysen; James A Swenberg; Brenda Temple; Sharon L Campbell; Stephen G Chaney
Journal:  Biochemistry       Date:  2007-05-12       Impact factor: 3.162

8.  Insight into the toxic effects of cis-dichloridoplatinum(II) complexes containing 7-azaindole halogeno derivatives in tumor cells.

Authors:  Tereza Muchova; Jitka Pracharova; Pavel Starha; Radana Olivova; Oldrich Vrana; Barbora Benesova; Jana Kasparkova; Zdenek Travnicek; Viktor Brabec
Journal:  J Biol Inorg Chem       Date:  2013-05-15       Impact factor: 3.358

9.  Treatment of DNA with ammonium bicarbonate or thiourea can lead to underestimation of platinum-DNA monoadducts.

Authors:  G R Gibbons; J D Page; S G Chaney
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

10.  Repair synthesis by human cell extracts in cisplatin-damaged DNA is preferentially determined by minor adducts.

Authors:  P Calsou; P Frit; B Salles
Journal:  Nucleic Acids Res       Date:  1992-12-11       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.